Analyst Activity – Chardan Capital Initiates Coverage On ArthroCare (NASDAQ:ARTC) With a Buy

ME Staff
-
0

Analyst Ratings For ArthroCare (NASDAQ:ARTC)

Today, Chardan Capital initiated coverage on ArthroCare (NASDAQ:ARTC) with a Buy.

Some recent analyst ratings include

  • 1/22/2018-Chardan Capital initiated coverage with a Buy rating.


    Recent Trading Activity for ArthroCare (NASDAQ:ARTC)
    Shares of ArthroCare closed the previous trading session at with shares trading hands.